These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10185751)

  • 1. Looking to the future.
    McCaffrey E
    Bus Health; 1998 Sep; 16(9 Suppl A):28-30. PubMed ID: 10185751
    [No Abstract]   [Full Text] [Related]  

  • 2. An update on pediatric immunization.
    Halsey NA
    Adv Pediatr Infect Dis; 1995; 10():187-225. PubMed ID: 7718207
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunization registry progress--United States, 2002.
    Can Commun Dis Rep; 2003 Jan; 29(1):1-4. PubMed ID: 12557468
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current problems in the vaccinal prevention of infectious diseases and the approaches to their resolution].
    Pokrovskiĭ VI; Litvinov SK; Bolotovskiĭ VM
    Ter Arkh; 1990; 62(11):3-7. PubMed ID: 2094986
    [No Abstract]   [Full Text] [Related]  

  • 5. Old legacies and new paradigms: confusing "research" and "treatment" and its consequences in responding to emergent health threats.
    Javitt GH
    J Health Care Law Policy; 2005; 8(1):38-70. PubMed ID: 16538801
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug and vaccine development for infectious diseases: the value of priority review vouchers.
    Matheny J; Smith B; Courtney B; Mair M
    Clin Pharmacol Ther; 2009 Jun; 85(6):571-2. PubMed ID: 19451907
    [No Abstract]   [Full Text] [Related]  

  • 7. Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.
    Kesselheim AS
    Clin Pharmacol Ther; 2009 Jun; 85(6):573-5. PubMed ID: 19451908
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination vaccines: problems and promise.
    Decker MD; Edwards KM
    J Pediatr; 2000 Sep; 137(3):291-5. PubMed ID: 10969248
    [No Abstract]   [Full Text] [Related]  

  • 9. Uncertainty surrounds cancer vaccine review at FDA.
    Fox JL
    Nat Biotechnol; 2007 Aug; 25(8):827-8. PubMed ID: 17687346
    [No Abstract]   [Full Text] [Related]  

  • 10. Malaria at the turn from the 2nd to the 3rd millenium.
    Wernsdorfer G; Wernsdorfer WH
    Wien Klin Wochenschr; 2003; 115 Suppl 3():2-9. PubMed ID: 15508773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric immunization update 2002.
    Paulson PR; Hammer AL
    Pediatr Nurs; 2002; 28(2):173-81. PubMed ID: 11962186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CANDA--an introduction, overview, and future visions.
    Nitahara K
    Qual Assur; 1993; 2(1-2):44-52. PubMed ID: 8156219
    [No Abstract]   [Full Text] [Related]  

  • 13. Measuring immunization coverage among preschool children: past, present, and future opportunities.
    Salmon DA; Smith PJ; Navar AM; Pan WK; Omer SB; Singleton JA; Halsey NA
    Epidemiol Rev; 2006; 28():27-40. PubMed ID: 16740586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunizations in the United States: success, structure, and stress.
    Orenstein WA; Douglas RG; Rodewald LE; Hinman AR
    Health Aff (Millwood); 2005; 24(3):599-610. PubMed ID: 15886150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional vaccines in cancer: the 'triad' approach.
    Nemunaitis J
    Expert Rev Vaccines; 2011 Jun; 10(6):713-5. PubMed ID: 21692693
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of medical progress on child health.
    Avery ME
    Health Matrix Clevel; 1994; 4(1):65-73. PubMed ID: 10142178
    [No Abstract]   [Full Text] [Related]  

  • 17. DNA vaccines: successes and limitations in cancer and infectious disease.
    Lowe DB; Shearer MH; Kennedy RC
    J Cell Biochem; 2006 May; 98(2):235-42. PubMed ID: 16440328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of developments in food and drug law from July 1998 to November 1999.
    Littlefield N; Hada NR
    Food Drug Law J; 2000; 55(1):35-56. PubMed ID: 12296348
    [No Abstract]   [Full Text] [Related]  

  • 19. Business barriers slowing the pace of cancer immunotherapy research and development.
    Tuma RS
    J Natl Cancer Inst; 2007 Nov; 99(21):1570-3. PubMed ID: 17971521
    [No Abstract]   [Full Text] [Related]  

  • 20. Food and Drug Administration approval of a fifth acellular pertussis vaccine for use among infants and young children--United States, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jul; 51(26):574. PubMed ID: 12139185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.